Surgical resection is a universal component of therapy against aggressive brain tumors. These cancers include glioblastoma (GBM) and medulloblastoma (MB), which are prevalent in older adults and children, respectively. Due to limited pre-clinical models, little is known about the post-operative microenvironment and how it impacts efficacy of local therapies. Cytotoxic stem cells (SCs) have emerged as a promising approach to target these aggressive post-surgical brain cancers, due in large part to their inherent tumor-homing properties. Our goal is to develop scaffold technology to improve stem cell therapy for post-surgical brain tumors. Though, in order to develop this new stem cell technology, there needs to be animal models in which to t...
Glioblastoma multiforme (GBM) is the most aggressive and fatal glioma that constitutes for roughly 4...
Triple-negative breast cancer (TNBC) is the most deadly subtype of breast cancer, with a high incide...
This review presents compelling evidence that human glioblastoma is a heterogenous tumor composed fr...
<div><p>Background</p><p>Cytotoxic neural stem cells (NSCs) have emerged as a promising treatment fo...
BACKGROUND:Cytotoxic neural stem cells (NSCs) have emerged as a promising treatment for Medulloblast...
Despite medical and technological advances, the survival statistics for patients diagnosed with glio...
Surgical resection is a universal component of glioma therapy. Little is known about the postoperati...
Tumor-homing cytotoxic stem cell (SC) therapy is a promising new approach for treating the incurable...
Medulloblastoma is the most common malignant brain tumor in children. Group 3 medulloblastoma is as...
Glioblastoma multiforme is a malignant tumor that grows in the human brain. Patients diagnosed with ...
According to the cancer stem cell hypothesis a subpopulation of cells within a tumour has the capaci...
Transdifferentiation (TD) is a recent advancement in somatic cell reprogramming. The direct conversi...
Engineered stem cell (SC)-based therapy holds enormous promise for treating the incurable brain canc...
PURPOSE: Medulloblastoma, a malignant pediatric brain tumor, is incurable in about one third of pati...
Cancers of the brain remain one of the greatest medical challenges. Traditional surgery and chemorad...
Glioblastoma multiforme (GBM) is the most aggressive and fatal glioma that constitutes for roughly 4...
Triple-negative breast cancer (TNBC) is the most deadly subtype of breast cancer, with a high incide...
This review presents compelling evidence that human glioblastoma is a heterogenous tumor composed fr...
<div><p>Background</p><p>Cytotoxic neural stem cells (NSCs) have emerged as a promising treatment fo...
BACKGROUND:Cytotoxic neural stem cells (NSCs) have emerged as a promising treatment for Medulloblast...
Despite medical and technological advances, the survival statistics for patients diagnosed with glio...
Surgical resection is a universal component of glioma therapy. Little is known about the postoperati...
Tumor-homing cytotoxic stem cell (SC) therapy is a promising new approach for treating the incurable...
Medulloblastoma is the most common malignant brain tumor in children. Group 3 medulloblastoma is as...
Glioblastoma multiforme is a malignant tumor that grows in the human brain. Patients diagnosed with ...
According to the cancer stem cell hypothesis a subpopulation of cells within a tumour has the capaci...
Transdifferentiation (TD) is a recent advancement in somatic cell reprogramming. The direct conversi...
Engineered stem cell (SC)-based therapy holds enormous promise for treating the incurable brain canc...
PURPOSE: Medulloblastoma, a malignant pediatric brain tumor, is incurable in about one third of pati...
Cancers of the brain remain one of the greatest medical challenges. Traditional surgery and chemorad...
Glioblastoma multiforme (GBM) is the most aggressive and fatal glioma that constitutes for roughly 4...
Triple-negative breast cancer (TNBC) is the most deadly subtype of breast cancer, with a high incide...
This review presents compelling evidence that human glioblastoma is a heterogenous tumor composed fr...